Stockholm:ALVO.SDB.ST

Transactions of Managers and Closely Associated Persons

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers…

3 weeks ago

Alvotech further strengthens liquidity by securing term loan facility of $75 million

July 01, 2026 04:00 ET  | Source: Alvotech — $75 million additional term loan facility maturing December 31, 2027, led…

3 weeks ago

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio

REYKJAVIK, Iceland, June 8, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture…

1 month ago